Functional characterization of autoantibodies against complement component C3 in patients with lupus nephritis

Journal of Biological Chemistry

Volumn 290, Issue 42, 2015, Pages 25343-25355

  Vasilev, Vasil V ^a   Noe, Remi ^b,c   Dragon Durey, Marie Agnes ^b,d,e,f   Chauvet, Sophie ^b,d,e,f   Lazarov, Valentin J ^a   Deliyska, Boriana P ^a   Fremeaux Bacchi, Veronique ^b,d,e,f   Dimitrov, Jordan D ^b,c,e   Roumenina, Lubka T ^b,d,e  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c PSL RESEARCH UNIVERSITY   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ENDOTHELIAL CELLS; SURFACE PLASMON RESONANCE;

AUTOIMMUNE DISEASE; COMPLEMENT SYSTEMS; FUNCTIONAL CHARACTERIZATION; FUNCTIONAL PROPERTIES; FUNCTIONAL RELEVANCE; HUMAN ENDOTHELIAL CELLS; MOLECULAR MECHANISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS;

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AUTOANTIBODY; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3 AUTOANTIBODY; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT FACTOR H; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C3;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; COHORT ANALYSIS; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; AUTOANTIBODIES; COHORT STUDIES; COMPLEMENT C3; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84944474598     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.647008     Document Type: Article

References (58)

1. Tsokos, G. C. (2011) Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110-2121
2. Radanova, M., Vasilev, V., Deliyska, B., Kishore, U., Ikonomov, V., and Ivanova, D. (2012) Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP. Immunobiology 217, 684-691
3. Vanhecke, D., and Roumenina, L. T., Wan, H., Osthoff, M., Schaller, M., and Trendelenburg, M. (2012) Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis Rheum. 64, 3706-3714
4. Cole, D. S., and Morgan, B. P. (2003) Beyond lysis: how complement influences cell fate. Clin. Sci. 104, 455-466
5. Merle, N. S., and Church, S. E., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015) Complement system part I: molecular mechanisms of activation and regulation. Front. Immunol. 6, 262
6. Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., and Roumenina, L. T. (2015) Complement system part II: role in immunity. Front. Immunol. 6, 257
7. Chen, Q., Muller, D., Rudolph, B., Hartmann, A., Kuwertz-Broking, E., Wu, K., Kirschfink, M., Skerka, C., and Zipfel, P. F. (2011) Combined C3b and factor B autoantibodies and MPGN type II. N. Engl. J. Med. 365, 2340-2342
8. Dragon-Durey, M. A., Loirat, C., Cloarec, S., and Macher, M. A., Blouin, J., Nivet, H., Weiss, L., and Fridman, W. H., and Frémeaux-Bacchi, V. (2005) Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16, 555-563
9. Pickering, M. C., and Botto, M. (2010) Are anti-C1q antibodies different from other SLE autoantibodies? Nat. Rev. Rheumatol. 6, 490-493
10. Lachmann, P. J. (2009) The amplification loop of the complement pathways. Adv. Immunol. 104, 115-149
11. Durand, C. G., and Burge, J. J. (1984) A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement: findings in systemic lupus erythematosus. J. Immunol. Methods 73, 57-66
12. Kenyon, K. D., Cole, C., Crawford, F., Kappler, J. W., and Thurman, J. M., Bratton, D.L., Boackle, S.A., and Henson, P. M. (2011) IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity. J. Immunol. 187, 2101-2111
13. Nilsson, B., and Ekdahl, K. N., Sjöholm, A., and Nilsson, U. R., and Sturfelt, G. (1992) Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course. Clin. Exp. Immunol. 90, 251-255
14. Nilsson, B., and Ekdahl, K. N., Svarvare, M., Bjelle, A., and Nilsson, U. R. (1990) Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Clin. Exp. Immunol. 82, 262-267
15. Potter, B. J., Brown, D.J., Watson, A., and Jewell, D. P. (1980) Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease. Gut 21, 1030-1034
16. Ngu, J. L., and Barratt, T. M., and Soothill, J. F. (1970) Immunoconglutinin and complement changes in steroid sensitive relapsing nephrotic syndrome of children. Clin. Exp. Immunol. 6, 109-116
17. Ngu, J. L., and Blackett, K. (1970) Complement and immunoconglutinin changes in the nephrotic syndrome of adult Africans. J. Trop. Med. Hyg. 73, 250-254
18. Rekvig, O. P., Putterman, C., Casu, C., Gao, H. X., Ghirardello, A., and Mortensen, E. S., Tincani, A., and Doria, A. (2012) Autoantibodies in lupus: culprits or passive bystanders? Autoimmun. Rev. 11, 596-603
19. Yaniv, G., Twig, G., Shor, D. B., Furer, A., Sherer, Y., Mozes, O., Komisar, O., Slonimsky, E., Klang, E., Lotan, E., Welt, M., Marai, I., Shina, A., Amital, H., and Shoenfeld, Y. (2015) A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun. Rev. 14, 75-79
20. Churg, J., Bernstien, J., and Glassock, R. (1995) Renal Disease: Classification and Atlas of Glomerular Diseases, 2nd Ed., p. 152, Igaku-Shoin, Ltd., New York
21. Marto, N., and Bertolaccini, M. L., Calabuig, E., Hughes, G.R., and Khamashta, M. A. (2005) Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 64, 444-448
22. Hay, E. M., and Bacon, P. A., Gordon, C., Isenberg, D. A., Maddison, P., and Snaith, M. L., Symmons, D. P., Viner, N., and Zoma, A. (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q. J. Med. 86, 447-458
23. Frimat, M., Tabarin, F., Dimitrov, J. D., Poitou, C., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., and Roumenina, L. T. (2013) Complement activationbyhemeas asecondary hit for atypical hemolytic uremic syndrome. Blood 122, 282-292
24. Roumenina, L. T., Frimat, M., Miller, E. C., Provot, F., Dragon-Durey, M. A., Bordereau, P., Bigot, S., Hue, C., Satchell, S. C., Mathieson, P. W., Mousson, C., Noel, C., Sautes-Fridman, C., Halbwachs-Mecarelli, L., Atkinson, J. P., Lionet, A., and Fremeaux-Bacchi, V. (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119, 4182-4191
25. Roumenina, L. T., Jablonski, M., Hue, C., Blouin, J., and Dimitrov, J. D., Dragon-Durey, M. A., Cayla, M., Fridman, W. H., Macher, M. A., Ribes, D., Moulonguet, L., Rostaing, L., Satchell, S. C., Mathieson, P. W., Sautes-Fridman, C., Loirat, C., Regnier, C. H., Halbwachs-Mecarelli, L., and Fremeaux-Bacchi, V. (2009) Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 114, 2837-2845
26. Józsi, M., Reuter, S., Nozal, P., López-Trascasa, M., Sánchez-Corral, P., Prohászka, Z., and Uzonyi, B. (2014) Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome. Immunol. Lett. 160, 163-171
27. Lachmann, P. J. (1967) Conglutinin and immunoconglutinins. Adv. Immunol. 6, 479-527
28. Lachmann, P. J., and Liske, R. (1966) The preparation and properties of alexinated intermediates that react with conglutinin. II. Equine, rabbit and human complement. Immunology 11, 255-262
29. Ngu, J. L., and Soothill, J. F. (1969) Immunoconglutinin and complement changes in children with acute nephritis. Clin. Exp. Immunol. 5, 557-566
30. Hautanen, A., Gripenberg, M., Salonen, E. M., Julkunen, I., and Laitinen, O. (1984) C3c-binding in inflammatory rheumatic diseases. Clin. Exp. Rheumatol. 2, 125-130
31. Marinozzi, M. C., Vergoz, L., Rybkine, T., Ngo, S., Bettoni, S., Pashov, A., Cayla, M., Tabarin, F., Jablonski, M., Hue, C., and Smith, R. J., Noris, M., Halbwachs-Mecarelli, L., Donadelli, R., Fremeaux-Bacchi, V., and Roumenina, L. T. (2014) Complement factor B mutations in atypical hemolytic uremic syndrome-disease: relevant or benign? J. Am. Soc. Nephrol. 25, 2053-2065
32. Wang, F. M., Yu, F., Tan, Y., Song, D., and Zhao, M. H. (2012) Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis. Rheumatology 51, 2269-2277
33. Bao, L., Haas, M., and Quigg, R. J. (2011) Complement factor H deficiency accelerates development of lupus nephritis. J. Am. Soc. Nephrol. 22, 285-295
34. Servais, A., Noël, L. H., Roumenina, L. T., Le Quintrec, M., Ngo, S., Dragon-Durey, M. A., Macher, M. A., Zuber, J., Karras, A., Provot, F., Moulin, B., Grünfeld, J. P., Niaudet, P., Lesavre, P., and Frémeaux-Bacchi, V. (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int. 82, 454-464
35. Sethi, S., and Fervenza, F. C. (2012) Membranoproliferative glomerulonephritis: a new look at an old entity. N. Engl. J. Med. 366, 1119-1131
36. Khera, R., and Das, N. (2009) Complement receptor 1: disease associations and therapeutic implications. Mol. Immunol. 46, 761-772
37. Birmingham, D. J., and Gavit, K. F., McCarty, S. M., Yu, C. Y., and Rovin, B. H., Nagaraja, H.N., and Hebert, L.A. (2006) Consumptionoferythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin. Exp. Immunol. 143, 274-280
38. Corvetta, A., Pomponio, G., Bencivenga, R., Luchetti, M. M., Spycher, M., and Spaeth, P. J., and Danieli, G. (1991) Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy. J. Rheumatol. 18, 1021-1025
39. Ross, G. D., and Yount, W. J., Walport, M. J., Winfield, J. B., and Parker, C. J., Fuller, C. R., Taylor, R. P., and Myones, B. L., and Lachmann, P. J. (1985) Disease-associated lossoferythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135, 2005-2014
40. Fyfe, A., and Holme, E. R., Zoma, A., and Whaley, K. (1987) C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 67, 300-308
41. Wilson, J. G., and Ratnoff, W. D., Schur, P. H., and Fearon, D. T. (1986) Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. 29, 739-747
42. Arora, M., Arora, R., Tiwari, S. C., Das, N., and Srivastava, L. M. (2000) Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis. Lupus 9, 127-131
43. Raju, K. R., Sivasankar, B., Anand, V., Luthra, K., and Tiwari, S. C., Dinda, A. K., Das, N., and Srivastava, L. M. (2001) Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies. Asian Pac. J. Allergy Immunol. 19, 23-27
44. Kavai, M. (2008) Immune complex clearance by complement receptor type 1 in SLE. Autoimmun. Rev. 8, 160-164
45. Kajander, T., and Lehtinen, M. J., Hyvärinen, S., Bhattacharjee, A., Leung, E., Isenman, D. E., Meri, S., Goldman, A., and Jokiranta, T. S. (2011) Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. U.S.A. 108, 2897-2902
46. Schramm, E. C., and Roumenina, L. T., Rybkine, T., Chauvet, S., Vieira-Martins, P., Hue, C., Maga, T., Valoti, E., Wilson, V., Jokiranta, S., Smith, R. J., Noris, M., Goodship, T., Atkinson, J. P., and Fremeaux-Bacchi, V. (2015) Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood 125, 2359-2369
47. Wu, J., and Wu, Y. Q., Ricklin, D., Janssen, B. J., and Lambris, J. D., and Gros, P. (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10, 728-733
48. Lambris, J. D., Lao, Z., Oglesby, T. J., and Atkinson, J. P., Hack, C. E., and Becherer, J. D. (1996) Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156, 4821-4832
49. Oran, A. E., and Isenman, D. E. (1999) Identification of residues within the 727-767 segment of human complement componentC3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274, 5120-5130
50. Leffler, J., and Bengtsson, A. A., and Blom, A. M. (2014) The complement system in systemic lupus erythematosus: an update. Ann. Rheum. Dis. 73, 1601-1606
51. Roumenina, L. T., Sène, D., Radanova, M., Blouin, J., Halbwachs-Mecarelli, L., Dragon-Durey, M. A., Fridman, W. H., and Fremeaux-Bacchi, V. (2011) Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J. Immunol. 187, 4369-4373
52. Goicoechea de Jorge, E., Harris, C. L., Esparza-Gordillo, J., Carreras, L., and Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., and Rodríguez de Córdoba, S. (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc. Natl. Acad. Sci. U.S.A. 104, 240-245
53. Paixão-Cavalcante, D., López-Trascasa, M., Skattum, L., Giclas, P. C., Goodship, T. H., de Córdoba, S. R., Truedsson, L., Morgan, B. P., and Harris, C. L. (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int. 82, 1084-1092
54. Dragon-Durey, M. A., Blanc, C., Marinozzi, M. C., van Schaarenburg, R. A., and Trouw, L. A. (2013) Autoantibodies against complement components and functional consequences. Mol. Immunol. 56, 213-221
55. Walport, M. J., and Davies, K. A., Botto, M., Naughton, M. A., and Isenberg, D. A., Biasi, D., Powell, R. J., and Cheung, N. T., and Struthers, G. R. (1994) C3 nephritic factor and SLE: report of four cases and review of the literature. QJM 87, 609-615
56. Jasin, H. E. (1979) Systemic lupus erythematosus, partial lipodystrophy and hypocomplementemia. J. Rheumatol. 6, 43-50
57. Kitahara, M., Koike, K., Kurokawa, Y., Sawai, N., Mori, T., Nakazawa, K., Shigematsu, H., and Komiyama, A. (1999) Lupus nephritis in juvenile myelomonocytic leukemia. Clin. Nephrol. 51, 314-318
58. Ben Ghorbel, I., Ben Salem, T., Lamloum, M., Braham, A., Khanfir, M., Miled, M., and Houman, M. H. (2010) [Barraquer-Simons syndrome in a patient with systemic lupus erythematosus]. Rev. Med. Interne. 31, 372-374